We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App




Mobile App Warns Diabetics of Dangerous Sugar Levels

By HospiMedica International staff writers
Posted on 14 Jan 2019
A new predictive tool analyzes blood glucose data to determine the likelihood of a hypoglyemic episode within the next several hours.

The Medtronic (Dublin, Ireland) Sugar.IQ app is a personal diabetes assistant with cognitive abilities that uses IBM (Armonk, NY, USA) Watson analytics capabilities to find patterns in diabetes data and offer real-time, personalized diabetes insights by continually analyzing how blood glucose levels respond to food intake, insulin dosages, daily routines, and other factors. More...
Together with the Guardian Connect continuous glucose monitor (CGM), the Sugar.IQ app can turn trend patterns into personalized diabetes care.

Sugar.IQ is powered by the IBM Watson IQcast feature, which uses artificial intelligence (AI) predictive modelling to improve prognostic capabilities over time. A study presented at the last American Diabetes Association Scientific Sessions, which was held in July 2018 in Orlando (FL, USA), showed that Sugar.IQ users are more likely to achieve an extra 36 minutes per day in a healthy glucose range of 70-180 mg/dL, experiencing 30 minutes less time per day in hyperglycemia, and six minutes less daily in hypoglycemia.

“Avoiding complications like hypoglycemia is a tremendous burden, but fortunately it is a problem that can help be alleviated by learning from data, which is where AI comes in,” said Lisa Latts, MD, deputy chief health officer at IBM Watson Health. “Using machine learning models and predictive algorithms, IQcast analyzes multiple signals coming from a user, such as glucose levels, insulin data, food logs, and prior hypoglycemic events to assess whether a user has a low, medium, or high chance of experiencing hypoglycemia within the upcoming four hours.”


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
Pulmonary Ventilator
OXYMAG
Exam Table
PF400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.